Clinical Trials Logo

Clinical Trial Summary

This investigation is a prospective, non-randomized, multi-center trial to evaluate the safety and effectiveness of the HAART model 300 annuloplasty ring when used to surgically repair a leaking aortic valve using a 3-D intra-annular mounting frame


Clinical Trial Description

Aortic Regurgitation, (also known as Aortic Insufficiency; AI), is the failure of the aortic valve to close completely during diastole which causes blood to flow from the aorta back into the left ventricle. Aortic Regurgitation (AR) is a frequent cause of both disability and death due to congestive heart failure, primarily in individuals forty or older, but can also occur in younger populations.

Traditionally management of aortic regurgitation has been by aortic valve replacement, however, as has been observed in patients who have had mitral valve repair, the option of maintaining ones native aortic valve versus a replacement, either bioprosthetic or mechanical, can have added multiple benefits. The advantage of repair is the avoidance of prosthetic valve-related complications with bioprosthetic valves over 10-15 years or the need for anticoagulation with mechanical valves and the related problems of this therapy. Therefore, potentially aortic valve repair is a good option for patients with AR or AI. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01400841
Study type Interventional
Source Biostable Science & Engineering
Contact
Status Completed
Phase N/A
Start date January 2012
Completion date September 2014

See also
  Status Clinical Trial Phase
Completed NCT03314857 - China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population N/A
Completed NCT03666351 - Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease Phase 4
Recruiting NCT06034028 - J-Valve TF Early Feasibility Study N/A
Completed NCT05515848 - Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David
Active, not recruiting NCT03549091 - Accuracy of Left Subclavian Regurgitation Evaluated by Ultrasound Doppler and 4D Flow MRI N/A
Completed NCT01598844 - JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation
Active, not recruiting NCT03466918 - China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population N/A
Active, not recruiting NCT04415047 - The JenaValve ALIGN-AR Pivotal Trial N/A
Not yet recruiting NCT05319171 - Performance of Currently Available traNscaTHEter Aortic Valve Platforms in Inoperable Patients With Pure Aortic regurgitatiON of a Native Valve. The PANTHEON International Project.
Completed NCT05774795 - LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated at the Time of Mitral Valve Surgery
Terminated NCT02351726 - Mitroflow DL Post Approval Study- North America N/A
Completed NCT00624884 - Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation N/A
Withdrawn NCT05409378 - HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation N/A
Recruiting NCT04038879 - Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation
Completed NCT05332184 - Cardiac T1 Mapping Enables Risk Prediction of LV Dysfunction After Surgery for Aortic Regurgitation
Not yet recruiting NCT02633423 - Expiratory Flow Limitation and Mechanical Ventilation During Cardiopulmonary Bypass in Cardiac Surgery N/A
Completed NCT00976625 - Diastolic Dysfunction in Aortic Regurgitation N/A
Enrolling by invitation NCT05714293 - CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement. N/A
Recruiting NCT02974920 - Rivaroxaban or Aspirin for Biological Aortic Prosthesis Phase 4
Not yet recruiting NCT03788590 - Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System N/A